OSR Health, Inc.
No SEC Form 4 filings for $OSRH in the last 30 days.
See all $OSRH insider activity →OSR Health, Inc. (OSRH) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001840425 0001840425 2026-08-07 2026-08-07 0001840425 OSRH:CommonStockParValue0.0001PerShareMember 2026-08-07 2026-08-07 0001840425 OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-08-07 2026-08-07 iso4217:USD xbrli:shares i
OSR Health, Inc. (NASDAQ:OSRH) clarified a July 31, 2026 press release about Nasdaq and its Shareholder Loyalty CVR Program. The company said Nasdaq’s earlier communication was only a preliminary, verbal technical indication about whether the program would mechanically adjust OSRH’s stock price, not approval or endorsement. The August 14, 2026 record date remains unchanged.
OSR Health, Inc. (NASDAQ:OSRH) said Nasdaq verbally communicated that its Shareholder Loyalty Contingent Value Rights (CVR) program will not cause any mechanical adjustment to OSRH’s common stock price when CVRs are distributed or when additional shares are delivered. The record date is Aug. 14, 2026, and enrolled holders receive extra shares if price milestones are met.
Over the past 7 days, alphai's AI scored 2 news stories mentioning OSRH (OSR Health, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent OSRH coverage spans corporate actions and market movers.
This is a routine corporate governance disclosure with no new operating or financial guidance, but it confirms shareholder approval of governance and capital-authorization items.
Clarification reduces the odds of an implied Nasdaq endorsement, which can affect CVR pricing expectations and near-term trading around the Aug 14 record date.
The Nasdaq clarification reduces event-driven uncertainty around OSRH’s CVR mechanics, lowering the risk of an exchange-imposed ex-date price haircut.
If the CVR program is approved and implemented, it creates a defined upside linkage to OSRH’s stock price, potentially supporting sentiment and trading activity into key dates.
The CVR-based loyalty program is positioned as an alternative to a reverse split, potentially affecting dilution expectations and short-selling dynamics.
alphai scores every news story that mentions OSRH with an AI model for sentiment and relevance, and aggregates insider trades from OSR Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
OSR Health, Inc. (OSRH) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001840425 0001840425 2026-08-07 2026-08-07 0001840425 OSRH:CommonStockParValue0.0001PerShareMember 2026-08-07 2026-08-07 0001840425 OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-08-07 2026-08-07 iso4217:USD xbrli:shares i
2 min readOSR Health, Inc. (NASDAQ:OSRH) clarified a July 31, 2026 press release about Nasdaq and its Shareholder Loyalty CVR Program. The company said Nasdaq’s earlier communication was only a preliminary, verbal technical indication about whether the program would mechanically adjust OSRH’s stock price, not approval or endorsement. The August 14, 2026 record date remains unchanged.
4 min readOSR Health, Inc. (NASDAQ:OSRH) said Nasdaq verbally communicated that its Shareholder Loyalty Contingent Value Rights (CVR) program will not cause any mechanical adjustment to OSRH’s common stock price when CVRs are distributed or when additional shares are delivered. The record date is Aug. 14, 2026, and enrolled holders receive extra shares if price milestones are met.
4 min readOSR Health, Inc. (NASDAQ:OSRH) CEO Peter Hwang outlined a proposed Shareholder Loyalty CVR Program. Hold through Aug. 14, 2026 measurement dates tied to price triggers from $2.00 to $5.00 to receive up to six times the original position via additional shares. The letter also cites VXM01 milestones up to $815M (PV about $94M) and a $15M put option exercisable Oct. 29, 2026.
4 min readEmerging Growth Research issued a flash report on OSR Health, Inc. (Nasdaq:OSRH), reaffirming a Buy rating and a $10.00 12-month price target. The report outlines OSRH’s approved Shareholder Loyalty Program using contingent value rights (CVRs) instead of a reverse split, with a July 31, 2026 record date and tiered CVR-based share rewards tied to stock-price milestones. It also cites an $815 million BCM Europe licensing deal for VXM01.
4 min read